Fatih Orkun KUNDAKTEPE
(Gaziosmanpaşa Taksim Education and Research Hospital)
Mustafa Genco ERDEM
(Istinye University)
Şerife Ayşen HELVACI
(Biruni University)
Yıl: 2018Cilt: 3Sayı: 3ISSN: 2564-6567 / 2564-6567Sayfa Aralığı: 152 - 155İngilizce

88 0
Comparison of three different creatinine clearance calculation methods in patients with type 2 diabetes mellitus
Aim: To determine the most accurate and useful method for calculating creatinine clearance by comparing the results of different methods. Methods: Type 2 Diabetic 100 patients who have been followed by Okmeydani Training and Research Hospital internal medicine and/or diabetes policlinics. Individuals with Type 1 Diabetes Mellitus and acute kidney disease were excluded from the study. Results: Glomerular filtration rate calculated with Cockroft-Gault formula was significantly affected by creatinine, weight and age (p<0.05 for all) in a univariate model. In a multivariate model this was significantly independently affected by creatinine, weight and age (p<0.05 for all). Glomerular filtration rate measured with Modification of Diet in Renal Disease formula was significantly affected by creatinine and age (p<0.05 for all) and in a univariate model. In a multivariate model this was significantly independently affected by creatinine (p<0.05). Glomerular filtration rate measured with 24h urine was significantly affected by creatinine, weight and age (p<0.05 for all). In a multivariate model this was significantly independently affected by weight (p<0.05). Conclusion: In this study, those three methods were similar and positively correlated to each other. Such findings prove that those three different methods are compatible with each other at glomerular filtration calculation and they are all useful in clinical practice. Practical and accurately intensive follow up of those patients will give a chance of better understanding this process and will help us with intervention as soon as possible when needed.
Fen > Tıp > Genel ve Dahili Tıp
DergiAraştırma MakalesiErişime Açık
  • 1. King H, Auert RE, Herman WH. Global burden of diabetes, 1995- 2025:Prevalence, numerical estimates,and projections. Diabetes Care. 1998;219:1414-31.
  • 2. Howlett HCS, Bailey CJ. A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Saf. 1999;20:489-503.
  • 3. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018. American Diabetes Association. Diabetes Care. 2018; 41:S105-18.
  • 4. Satman I, Yilmaz T, Sengül A, Salman S, Salman F, Uygur S et al. Population-based study of diabetes and risk characteristics in Turkey: results of the turkish diabetes epidemiology study (TURDEP). Diabetes Care. 2002;25:1551-6.
  • 5. Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease. With an emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32:64-78.
  • 6. Cockroft DW, Gault MH. Prediction of Creatinine Clearance from serum creatinine Nephron. 1976;16:31-41.
  • 7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A More Accurate to Estimate Glomerular Filtration Rate From Serum Creatinine; A New Prediction Equation. Ann Int Med. 1999;130:461-70.
  • 8. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Supp. 2013:1-150.
  • 9. Willems JM, Vlasveld T, den Elzen WP, Westendorp RG, Rabelink TJ, de Craen AJ et al. Performance of Cockcroft-Gault, MDRD, and CKD-EPI in estimating the prevalence of renal function and predicting survival in the oldest old. BMC Geriatrics. 2013;13:113.
  • 10. Teruel JL, Sabater J, Galeano C. The Cockcroft-Gault equation is better than MDRD equation to estimate the glomerular filtration rate in patients with advanced chronic renal failure. Nefrologia. 2007;27:313-9.
  • 11. Helou R. Should We Continue to Use the Cockcroft-Gault Formula? Nephron Clin Pract. 2010;116:172–86.
  • 12. Tiao JY, Semmens JB, Masarei JR, Lawrence-Brown MM. The effect of age on serum creatinine levels in an aging population: relevance to vascular surgery. Cardiovasc Surg. 2002;10:445-51.
  • 13. Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003-9.
  • 14. Rigalleau V, Lasseur C, Perlemoine C, Barthe N, Raffaitin C, Chauveau P et al. Cockcroft-Gault formula is biased by body weight in diabetic patients with renal impairment. Metabolism. 2006;55:108-12.
  • 15. Brown DL, Masselink AJ, Lalla CD. Functional range of creatinine clearance for renal drug dosing: a practical solution to the controversy of which weight to use in the Cockcroft-Gault equation. Ann Pharmacother. 2013;47:1039-44.
  • 16. Carter JL, Stevens PE, Irving JE, Lamb EJ. Estimating glomerular filtration rate: comparison of the CKD-EPI and MDRD equations in a large UK cohort with particular emphasis on the effect of age. QJM. 2011;104:839-47.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.